JENNIFER BOWRING: Open Payments
NPI 1265080287 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 20 payments from 11 companies in 2025. Trend: 2023 $1,046 · 2024 $665 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $95 |
| Novo Nordisk Inc | 3 | $63 |
| ABBVIE INC. | 3 | $50 |
| Lilly USA, LLC | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ViiV Healthcare Company | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, OTEZLA, ACCRUFER, Wegovy, JASCAYD, UBRELVY, SPRAVATO.
Industry payments across TX — which companies pay providers there.
